Pictet North America Advisors’s Idexx Laboratories IDXX Stock Holding History

Pictet North America Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,297	Closed	-$819K	–	129
2021 Q2	$819K	Sell	1,297 -115	-8%	-$63.5K	0.08%	83
2021 Q1	$691K	Sell	1,412 -31	-2%	-$15.5K	0.08%	86
2020 Q4	$721K	Sell	1,443 -14	-1%	-$6.26K	0.09%	89
2020 Q3	$573K	Buy	1,457 +250	+21%	+$92.4K	0.08%	97
2020 Q2	$399K	Hold	1,207	–	–	0.06%	112
2020 Q1	$292K	Buy	+1,207	New	+$315K	0.05%	119

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pictet North America Advisors's IDXX Position: Q3 2021 in Review

Pictet North America Advisors sold out of Idexx Laboratories (IDXX) in Q3 2021, closing a stake of 1,297 shares — an estimated $819K sold.

Pictet North America Advisors first reported a position in IDXX in Q1 2020 and held it in 6 quarters. The position peaked at $819K in Q2 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

Pictet North America Advisors reported no remaining Idexx Laboratories position as of Q3 2021 after selling out during the quarter.
Pictet North America Advisors sold 1,297 Idexx Laboratories shares in Q3 2021, an estimated $819K.
Pictet North America Advisors first reported a position in Idexx Laboratories in Q1 2020 and held it in 6 quarters.
Pictet North America Advisors's Idexx Laboratories position peaked at $819K in Q2 2021.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Pictet North America Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.